Bristol-Myers Squibb Collaboration Adds New Dimension To Oncology Valuation Story [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Bristol-Myers Squibb, NYSE:BMY, has entered a new collaboration with Oxford BioTherapeutics to develop T-cell engager therapies for solid tumours. The alliance focuses on using Oxford BioTherapeutics' target discovery technologies to identify and advance next-generation oncology candidates. This development expands Bristol-Myers Squibb's oncology pipeline and adds fresh assets to its research and development efforts. For investors watching NYSE:BMY, this collaboration comes as the stock trades around $60.17, with a value score of 4 and a mixed set of longer term returns. The share price performance shows a 2.6% return over the past week, 4.7% over the past month, and 12.6% year to date, alongside a 28.3% return over 1 year, a 1.9% decline over 3 years, and an 11.4% return over 5 years. The Oxford BioTherapeutics agreement adds another layer to Bristol-Myers Squibb's oncology story, particularly in solid tumours where T-cell engagers are still at an early stage for many compan
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Moderna's mRNA Melanoma Data And Fast Track Status Shape Oncology Story [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (BMY) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=BMY&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "buy" MarketBeat
- Bristol-Myers Squibb: The Market Is Not Pricing The Growth Portfolio That Replaces The Patent Cliff [Seeking Alpha]Seeking Alpha
- The innovators working to make in vivo cell therapy a reality [Yahoo! Finance]Yahoo! Finance
- ??????2035????549???????? ??????????????????????? CAGR22.66% : ???????????????????? [CNET News]CNET News
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 4/17/26 - Form DEFA14A
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- BMY's page on the SEC website